Enhancing Pharmacovigilance Practices: Insights from Audits and Ethical Connotations
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11240%2F24%3A10487000" target="_blank" >RIV/00216208:11240/24:10487000 - isvavai.cz</a>
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=jj5pTXkbqJ" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=jj5pTXkbqJ</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.36290/csf.2024.033" target="_blank" >10.36290/csf.2024.033</a>
Alternative languages
Result language
angličtina
Original language name
Enhancing Pharmacovigilance Practices: Insights from Audits and Ethical Connotations
Original language description
Pharmacovigilance, pivotal in ensuring drug safety and regulatory compliance, requires meticulous surveillance and adherence to ethical standards. This article explores the multifaceted realm of pharmacovigilance, emphasizing the essential role of pharmacovigilance audits and compliance monitoring. By delving into key areas such as drug safety surveillance, signal detection, literature monitoring, and ethical considerations, this research sheds light on critical aspects of pharmacovigilance activities. The paper examines the outcomes of pharmacovigilance audits, highlighting common findings and areas for improvement to enhance regulatory compliance and the safety of pharmaceutical products. Insights gleaned from real-world experiences and regulatory guidelines underscore the importance of fostering a culture of good practice and ethical conduct in pharmacovigilance activities. By addressing challenges and trends, and elucidating the critical interaction between regulatory compliance, signal detection, and ethical considerations, this article provides valuable insights for stakeholders in the pharmaceutical industry, aiding them in optimizing pharmacovigilance systems and safeguarding patient safety.
Czech name
—
Czech description
—
Classification
Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
30311 - Medical ethics
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Česká a slovenská farmacie
ISSN
1210-7816
e-ISSN
1805-4439
Volume of the periodical
73
Issue of the periodical within the volume
3
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
10
Pages from-to
13-22
UT code for WoS article
—
EID of the result in the Scopus database
2-s2.0-85218621877